MXCT 8-K 2026-10-14
MAXCYTE, INC. (MXCT) 8-K dated 2026-10-14 — accession 0001104659-26-115745. This URL is the filing, not the MXCT hub.
MAXCYTE, INC. (MXCT) is a medical devices company listed on NASDAQ.
MXCT: SECURITIES AND EXCHANGE COMMISSION
Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.
Latest reported MXCT revenue for 2025-12-31 was $33.0M. Net income was -$44.6M. Revenue was down 14.5% from 2024-12-31 to 2025-12-31. MXCT currently screens at market cap $124.3M.
Not investment advice. The MXCT SEC hub lists recent forms. The stock page is the research view.
- Guidance
- full-year 2026 revenue guidance. A copy of the press release is furnished as
Why it matters
- full-year 2026 revenue guidance. A copy of the press release is furnished as